Ledger. Australian venture funding, tracked

Partner, SV Health Investors

Jamil M. Beg

Coverage

Stories naming Jamil M. Beg. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Series C US$112m

AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing

Sydney cancer-therapy developer AdvanCell has completed a US$112 million Series C that was oversubscribed, co-led by four investors, with Brandon Capital among new backers; three investor representatives join the board.

Also Startup Daily·SmartCompany·Forbes Australia

Something wrong? Tell us